Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, February 01, 2015
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Non Ducted Fume Cupboards
Tuesday, January 27, 2015
Asynt new range of high quality fume cupboards designed to sit on a standard laboratory bench.

US CRO Expands Flow Chemistry Capabilities
Thursday, January 15, 2015
Regis will use new R-Series flow chemistry system to accelerate process research and development and to perform unique chemical reactions.

20,000 Hours and Counting
Friday, January 09, 2015
Grant Optima™ circulating water baths are used in research, educational, industrial and clinical labs.

Chemistry on Wheels
Friday, December 26, 2014
Evonik’s EcoTrainer is flexible, clever and smart: a single container can house a complete chemical production complex.

High Quality Affordable Reaction Vessels
Friday, December 26, 2014
Addition of the AG! reactor vessel range extends the scale of reactors up to 160 L, or up to 60 L.

Bigneat Announces Optiflow, a New Style of Safety Workstation
Tuesday, November 25, 2014
Recirculatory filtration fume system has consistent airflow ensuring the integrity of the ‘working safe-zone’ and providing the user with unhindered accessibility.

Asynt PressureSyn Wins Innovation Award
Tuesday, November 18, 2014
A high pressure reactor designed to work on any magnetic hotplate stirrer.

Immersion Coolers for Flexible Cooling Down to -100 °C
Friday, November 07, 2014
A flexible solution for a variety of cooling applications.

New Precision Balances: Reliable, Compliant and Intuitive
Monday, November 03, 2014
METTLER TOLEDO's Excellence XPE precision balances make daily weighing tasks fast, easy and error-free.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 926
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn